Application

LONGBOARD

Arena Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90232096
Filing Date: 10/02/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90232096
MARK INFORMATION
*MARK LONGBOARD
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT LONGBOARD
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Arena Pharmaceuticals, Inc.
*MAILING ADDRESS 6154 Nancy Ridge Drive
*CITY San Diego
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92121
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceutical preparations for human use; biological preparations for human use; pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system; biological preparations for the treatment of disorders of the central nervous system
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, biologics, clinical trials and post-market trials; research and development services in the fields of pharmaceuticals, biologics and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals and biologics; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Providing medical information
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Allison Strickland Ricketts
ATTORNEY DOCKET NUMBER ARPI 2009652
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME FROSS ZELNICK LEHRMAN & ZISSU, P.C.
STREET 151 West 42nd St., 17th Fl
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
PHONE 212-813-5967
EMAIL ADDRESS ricketts-docket@fzlz.com
OTHER APPOINTED ATTORNEY Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger
CORRESPONDENCE INFORMATION
NAME Allison Strickland Ricketts
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ricketts-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 825
*TOTAL FEES PAID 825
SIGNATURE INFORMATION
SIGNATURE /Shannon K. Carter/
SIGNATORY'S NAME Shannon K. Carter
SIGNATORY'S POSITION VP, Intellectual Property
SIGNATORY'S PHONE NUMBER 858-453-7200
DATE SIGNED 10/02/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90232096
Filing Date: 10/02/2020

To the Commissioner for Trademarks:

MARK: LONGBOARD (Standard Characters, see mark)
The literal element of the mark consists of LONGBOARD. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Arena Pharmaceuticals, Inc., a corporation of Delaware, having an address of
      6154 Nancy Ridge Drive
      San Diego, California 92121
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  pharmaceutical preparations for human use; biological preparations for human use; pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system; biological preparations for the treatment of disorders of the central nervous system
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, biologics, clinical trials and post-market trials; research and development services in the fields of pharmaceuticals, biologics and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals and biologics; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Providing medical information
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Allison Strickland Ricketts. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Nancy Sabarra, Karen Lim, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger. Allison Strickland Ricketts of FROSS ZELNICK LEHRMAN & ZISSU, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      151 West 42nd St., 17th Fl
      New York, New York 10036
      United States
      212-813-5967(phone)
      ricketts-docket@fzlz.com
The docket/reference number is ARPI 2009652.
Allison Strickland Ricketts submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Allison Strickland Ricketts
       PRIMARY EMAIL FOR CORRESPONDENCE: ricketts-docket@fzlz.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Shannon K. Carter/   Date: 10/02/2020
Signatory's Name: Shannon K. Carter
Signatory's Position: VP, Intellectual Property
Payment Sale Number: 90232096
Payment Accounting Date: 10/02/2020

Serial Number: 90232096
Internet Transmission Date: Fri Oct 02 13:31:28 ET 2020
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2020100213312803
6382-90232096-750dc64ee91479d8fd544e711c
bd1c17297448c27d2cf97881b986fa7281194c-D
A-31273517-20201001095809893320

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed